Karo Healthcare’s Acquisition of Lamisil from Haleon for £235M

Allen & Overy advised Haleon plc on divestiture of Lamisil.Haleon plc effectively sold its Lamisil brand across more than 70 jurisdictions to Karo Healthcare AB, securing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Georgio Naffaa

This content is for Standard 1 Year members only.
Login Join Now